Advancing Ocular Therapeutics
Our Mission
We are dedicated to ocular therapy and drug delivery that transform the treatment of low vision retinal diseases. By merging innovative research and technology, we aim to restore clarity and hope to patients.
Flagship Asset: CM-20
High-Value Non-Invasive Nano-gel Therapy
Thera Vision’s lead program, CM-20, is a first-in-class multi-target drug therapy strategically positioned to the massive, untapped market for non-advanced AMD, where over 150 million patients globally currently lack any approved treatment options. By utilizing our proprietary nanoparticle platform, CM-20 delivers a non-invasive topical nano-gel that ensures high compliance and safety compared to invasive injections. This disruptive technology not only captures significant early-stage market share but also offers a highly scalable platform validated for expansion across a wide range of high-value ocular indications.
Grant Support & Awards
The development of our flagship CM-20 nano-gel therapy for AMD has been supported by grant awards from National Institutes of Health/National Eye Institute, Illinois Innovation Voucher, and Illinois Department of Commerce and Economic Opportunity.
Redefine Eyecare
Targeted Ocular Delivery
Advanced nano-formulations designed to penetrate ocular barriers with enhanced bioavailability, ensuring maximum therapeutic impact.
Sustainable Release
Long-acting and generally safe biodegradable nano-formulation designs that provide consistent drug concentration over extended periods, reducing the frequency of treatments and better safety outcomes.
Multitarget Retinal Protection
Retinal diseases have complex etiology, adding significant challenges for therapy. We explore novel poly-pharmacology strategy (multitarget drugs) to simultaneously block multiple degenerative targets for vision restoration.
Science & Technology
Collaborate with Thera Vision
2242 W Harrison St., Suite 201, Chicago, IL 60612
We invite pharma, biotech, and academic partners for collaborations to advance ocular therapy and drug delivery. Please provide your information below to begin the process.